Evidence map›Paper›PMID 27180107›Full record

Trial reportPharmacology, biochemistry, and behavior2016

Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking.

Kathryn C Ross, Noah R Gubner, Rachel F Tyndale, Larry W Hawk, Caryn Lerman, Tony P George, Paul Cinciripini, Robert A Schnoll, Neal L Benowitz

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Pharmacology, biochemistry, and behavior, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 60 citations in OpenAlex.

  1. Relationships Between the Nicotine Metabolite Ratio and Laboratory Assessments of Smoking Reinforcement and Craving Among Adults in a Smoking Cessation Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Urinary anatalline and nicotelline cut-points to distinguish between exclusive and dual use of tobacco products.Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2024
    Article
  12. Associations Between Childhood Trauma and Tobacco Use Outcomes in Adults after Overnight Abstinence.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Exploring Potential for a Personalized Medicine Approach to Smoking Cessation With an American Indian Tribe.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Article
  18. Article
  19. Article
  20. Urinary Nicotine Metabolites and Self-Reported Tobacco Use Among Adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Kathryn C RossCenter for Tobacco Control Research and Education, University of California San Francisco, San Francisco, CA, USA.
Noah R GubnerCenter for Tobacco Control Research and Education, University of California San Francisco, San Francisco, CA, USA.
Rachel F TyndaleCentre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.
Larry W HawkDepartment of Psychology University at Buffalo, SUNY, Buffalo, NY, USA.
Caryn LermanDepartment of Psychiatry and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Annenberg School for Communication, University of Pennsylvania, Philadelphia, PA, USA.
Tony P GeorgeCentre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Paul CinciripiniDepartment of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Robert A SchnollDepartment of Psychiatry and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Neal L BenowitzCenter for Tobacco Control Research and Education, University of California San Francisco, San Francisco, CA, USA; Division of Clinical Pharmacology and Experimental Therapeutics, Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA. Electronic address: neal.benowitz@ucsf.edu.
University of California, San Francisco · USUniversity of Pennsylvania · USCentre for Addiction and Mental Health · CAThe University of Texas MD Anderson Cancer Center · USUniversity at Buffalo, State University of New York · USUniversity of Toronto · CA

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Robert H. Vonderheide · 1985 to 2026
$222.3M
University of Toronto Coordinating Genetics Core & Clinical Trial SiteU01DA020830 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI CONTI, DAVID V · 2005 to 2014
$22.4M
Postdoctoral training in tobacco controlR25CA113710 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLANTZ, STANTON ARNOLD · 2006 to 2015
$5.4M
Postdoctoral training in tobacco controlT32CA113710 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LING, PAMELA MAY · 2016 to 2020
$2.6M
Cognitive and Behavioral Effects of Sleep Restriction in Adolescents with ADHDR03MH109787 · NIMH · CINCINNATI CHILDRENS HOSP MED CTR · PI BECKER, STEPHEN P · 2016 to 2017
$156k
CIHR TMH109787NCI NIH HHS P30 CA016520NCI NIH HHS R25 CA113710NCI NIH HHS T32 CA113710NIDA NIH HHS U01 DA020830NIMH NIH HHS R03 MH109787
6 · The paper itself

Abstract

Rate of nicotine metabolism has been identified as an important factor influencing nicotine intake and can be estimated using the nicotine metabolite ratio (NMR), a validated biomarker of CYP2A6 enzyme activity. Individuals who metabolize nicotine faster (higher NMR) may alter their smoking behavior to titrate their nicotine intake in order to maintain similar levels of nicotine in the body compared to slower nicotine metabolizers. There are known racial differences in the rate of nicotine metabolism with African Americans on average having a slower rate of nicotine metabolism compared to Whites. The goal of this study was to determine if there are racial differences in the relationship between rate of nicotine metabolism and measures of nicotine intake assessed using multiple biomarkers of nicotine and tobacco smoke exposure. Using secondary analyses of the screening data collected in a recently completed clinical trial, treatment-seeking African American and White daily smokers (10 or more cigarettes per day) were grouped into NMR quartiles so that the races could be compared at the same NMR, even though the distribution of NMR within race differed. The results indicated that rate of nicotine metabolism was a more important factor influencing nicotine intake in White smokers. Specifically, Whites were more likely to titrate their nicotine intake based on the rate at which they metabolize nicotine. However, this relationship was not found in African Americans. Overall there was a greater step-down, linear type relationship between NMR groups and cotinine or cotinine/cigarette in African Americans, which is consistent with the idea that differences in blood cotinine levels between the African American NMR groups were primarily due to differences in CYP2A6 enzyme activity without titration of nicotine intake among faster nicotine metabolizers.

Indexed as

SmokingTobacco ProductsAdultAgedBlack or African AmericanCarbon MonoxideCotinineCytochrome P-450 CYP2A6FemaleHumansMaleMiddle AgedNicotineWhite PeopleCarbon MonoxideCotinineCYP2A6 protein, humanCytochrome P-450 CYP2A6NicotineAfrican American smokersBiomarkersNicotine intakeNicotine metabolismNicotine titrationRacial differences

Identifiers

PMID27180107
PMCPMC4972680
OpenAlexW2388180246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.